261 related articles for article (PubMed ID: 17267290)
41. Newer antiepileptic drugs and cognitive issues.
Aldenkamp AP; De Krom M; Reijs R
Epilepsia; 2003; 44 Suppl 4():21-9. PubMed ID: 12823566
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
Asadi-Pooya AA; Sperling MR; Chung S; Klein P; Diaz A; Elmoufti S; Schiemann J; Whitesides J
Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
[TBL] [Abstract][Full Text] [Related]
43. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015.
Du Y; Lin J; Shen J; Ding S; Ye M; Wang L; Wang Y; Wang X; Xia N; Zheng R; Chen H; Xu H
BMC Pharmacol Toxicol; 2019 Jan; 20(1):7. PubMed ID: 30642405
[TBL] [Abstract][Full Text] [Related]
44. Bone mineral density in adult patients treated with various antiepileptic drugs.
Beniczky SA; Viken J; Jensen LT; Andersen NB
Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
[TBL] [Abstract][Full Text] [Related]
45. [Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy].
Thomas P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S252-64. PubMed ID: 15331973
[TBL] [Abstract][Full Text] [Related]
46. An in vitro study of new antiepileptic drugs and astrocytes.
Pavone A; Cardile V
Epilepsia; 2003; 44(s10):34-9. PubMed ID: 14511393
[TBL] [Abstract][Full Text] [Related]
47. [Current pharmacotherapy of epilepsy in adults].
Beyenburg S
Bull Soc Sci Med Grand Duche Luxemb; 2005; (3):263-81. PubMed ID: 17176542
[TBL] [Abstract][Full Text] [Related]
48. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
[TBL] [Abstract][Full Text] [Related]
49. [Efficacy of epilepsy treatments with different drugs].
Kotov AS; Belova IuA
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):37-40. PubMed ID: 23235410
[TBL] [Abstract][Full Text] [Related]
50. [Risks and benefits of new antiepileptic agents in children].
Aicardi J
Rev Neurol; 2000 Aug 16-31; 31(4):376-81. PubMed ID: 11008295
[TBL] [Abstract][Full Text] [Related]
51. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
Contin M; Alberghini L; Candela C; Benini G; Riva R
Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
53. Patient-reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs.
Arif H; Buchsbaum R; Weintraub D; Pierro J; Resor SR; Hirsch LJ
Epilepsy Behav; 2009 Jan; 14(1):202-9. PubMed ID: 19010446
[TBL] [Abstract][Full Text] [Related]
54. Effects of treatment with clinically relevant valproate, carbamazepine, oxcarbazepine, topiramate, lamotrigine and levetiracetam on ovarian folliculogenesis in young rats.
Cansu A; Gurgen SG; Demirhan YN; Ozkan Kart P; Yildirim M; Alver A; Yeni Lmez E; Sönmez FM
Epilepsy Res; 2022 Aug; 184():106966. PubMed ID: 35763982
[TBL] [Abstract][Full Text] [Related]
55. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
[TBL] [Abstract][Full Text] [Related]
56. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
Mula M; Trimble MR; Sander JW
Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462
[TBL] [Abstract][Full Text] [Related]
57. [Controversies about the new anti-epileptic drugs].
Serrano Castro PJ; Sánchez Alvarez JC
Rev Neurol; 2001 Jan 16-31; 32(2):165-71. PubMed ID: 11299481
[TBL] [Abstract][Full Text] [Related]
58. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
[TBL] [Abstract][Full Text] [Related]
59. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.
Carpay JA; Aalbers K; Graveland GA; Engelsman M
Seizure; 2009 Mar; 18(2):119-23. PubMed ID: 18760635
[TBL] [Abstract][Full Text] [Related]
60. New antiepileptic agents.
Nelson LP; Savelli-Castillo I
Pediatr Dent; 2004; 26(1):58-62. PubMed ID: 15080360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
